The development of new antiretroviral agents may improve survival of HIV-infected individuals, and therefore chronic viral hepatitis may become more relevant in these patients. The presence of GBV-C/HGV and hepatitis C virus (HCV) RNA were investigated by reverse transcriptasenested polymerase chain
Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in Germany
✍ Scribed by Markus Neibecker; Carolynne Schwarze-Zander; Jürgen K. Rockstroh; Ulrich Spengler; Jason T. Blackard
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 731 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Multiple genotypes of GB virus C (GBV-C)-a non-pathogenic flavivirus-have been identified to date, although they are not uniformly distributed worldwide. It has also been suggested that GBV-C genotype may play a role in modulating HIV disease; however, the prevalence and genotype distribution of GBV-C has not been adequately studied in most countries. Among 408 HIV positive subjects in Germany, 97 (23.8%) had detectable GBV-C RNA. Based on sequencing of the 5 0 untranslated region (5 0 -UTR), the GBV-C genotypes were 1 (n ¼ 8; 8.2%), 2 (n ¼ 81; 83.5%), and 3 (n ¼ 2; 2.1%), as well as a unique genotype not previously reported (n ¼ 6; 6.2%). Among 17 samples also sequenced in the envelope 2 (E2) region, 14 had concordant genotype results when comparing the 5 0 -UTR and E2, while evidence of intergenotypic recombination was observed among E2 sequences from 3 individuals. These results suggest that genotypic diversity and viral recombination contribute to the overall genetic variability of GBV-C.
📜 SIMILAR VOLUMES
The viral genome of GB virus C/hepatitis G virus (GBV-C/HGV), a single-strand RNA virus, is subject to considerable variability and at least four genotypes have been suggested based on phylogenetic analysis. While co-infection of GBV-C/HGV with other infectious agents such as hepatitis C virus (HCV)
During 1994 and 1995, the prevalence of hepatitis C virus (HCV) and its genotypes were studied in several rural and urban populations in three West African countries: Guinea, Burkina Faso, and Benin. The following groups were screened for antibodies to HCV (anti-HCV): 459 villagers in the forest reg